Live Breaking News & Updates on மேத்யூ ஹாங்

Stay updated with breaking news from மேத்யூ ஹாங். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Plant-based "vaccine" uses herbs to activate the immune system against the coronavirus, without the blood clot risk


https://www.afinalwarning.com/512985.html
(Natural News)
Canadian company Medicago has developed a plant-based vaccine for the Wuhan coronavirus (COVID-19). The two-dose vaccine uses virus-like particles (VLP) grown in a tobacco shrub to confer immunity against COVID-19.
VLPs are molecules that closely resemble a virus. They are not infectious since they do not contain genetic material. Vaccines that use VLPs train the immune system to recognize a virus and launch an attack if a person gets infected.
Medicago’s vaccine is different from all authorized COVID-19 vaccines. Whereas other vaccines target only the spike protein, the molecule used by the coronavirus to infect host cells, the plant-based shot uses VLPs that resemble the overall structure of the Wuhan coronavirus. ....

United States , North Carolina , Matthew Hong , Mark Carlson , Kwanchai Wisitthanon , Wake Research , Thailand Ministry Of Public Healthapproved , Department Of Thai Traditional , Natural News , Traditional Chinese Medicine , Thai Traditional , Alternative Medicine , Public Healthapproved , Corona Virus , Disease Treatments , Herbal Medicine , Infectious Diseases , Science Amp Tech , Covid 19 , Covid 19 Immunity , Good Health , Immune System , Medical Science , Plant Based Vaccine , Spike Protein , Wuhan Coronavirus ,

COVID-19 Plant Extract: Clinical Trial Begins For Vaccine Made From Tobacco Plant


Apr 22, 2021 03:16 PM EDT
Scientists all over the country are testing a new two-dose COVID-19 vaccine candidate that is based on plants. Produced by Medicago vaccination, a biopharmaceutical company in Canada, the shot makes use of tobacco shrub to manufacture coronavirus-like particles.They help the body to be aware of the pathogen so that it can bring about an immune response and set an attack in motion if a person becomes infected.
(Photo : Getty Images)
Virus-like Particles (VLPs). 
If the late-stage clinical trial confirms the candidate is successful, it could be quicker and less expensive to make - and easier distribution - than other vaccines that are available.  ....

North Carolina , United States , Matthew Hong , Mark Carlson , Centers For Disease , Drug Administration , Wake Research In Raleigh , Getty Images , Fauci Warns About Side Effects , Should Watch Out , Wake Research , Disease Control , Goes Into Shock After Mistakenly Getting , வடக்கு கரோலினா , ஒன்றுபட்டது மாநிலங்களில் , மேத்யூ ஹாங் , குறி கார்ல்சன் , மையங்கள் க்கு நோய் , எழுந்திரு ஆராய்ச்சி இல் ராலே , கெட்டி படங்கள் , எழுந்திரு ஆராய்ச்சி , நோய் கட்டுப்பாடு ,